Evidence map›Paper›PMID 42670621›Full record

ReviewJournal of the National Cancer Institute. Monographs2026

How practically feasible is tailored screening for cervical cancer based on human papillomavirus vaccination status?: the role of data linkage and registers.

Partha Basu, Eric Lucas, K Miriam Elfström

Abstract readReview
In one paragraph

Review in Journal of the National Cancer Institute. Monographs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Partha BasuEarly Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0003-0124-4050
Eric LucasEarly Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France.
K Miriam ElfströmCenter for Cervical Cancer Elimination, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0002-0514-7226

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is substantial evidence examining effectiveness of human papillomavirus vaccines in populations using registry linkages. These studies initially mapped early outcomes, but in recent years have focused on harder endpoints, confirming that the vaccines have the anticipated effect against infection, lesions, and ultimately invasive cervical cancer. It is generally accepted that when vaccinated cohorts enter screening programs, adjustments to screening strategies are needed to maintain the balance of benefits and harms and achieve optimal resource use. The purpose of this chapter is to examine the practical considerations for implementing tailored screening in the context of increasingly vaccinated populations, with particular emphasis on data sources and their application in routine practice. We present real-world examples of linking vaccination and screening registries to enable screening strategies informed by individual human papillomavirus vaccination status. We also outline the common challenges encountered when establishing such linkages and offer practical suggestions for overcoming them.

Indexed as

Early Detection of CancerInformation Storage and RetrievalPapillomavirus VaccinesRegistriesUterine Cervical NeoplasmsVaccinationFeasibility StudiesFemaleHealth Plan ImplementationHumansPapillomavirus InfectionsPapillomavirus Vaccines

Identifiers

PMID42670621
PMCPMC13527424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.